First Manhattan
EOLS icon

First Manhattan’s Evolus EOLS Stock Holding History

First Manhattan’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,000
Closed -$1.38M – 721
2025
Q2 		$1.38M Buy
150,000
+110,000
+275% +$1.13M ﹤0.01% 377
2025
Q1 		$481K Hold
40,000
– – ﹤0.01% 508
2024
Q4 		$442K Hold
40,000
– – ﹤0.01% 524
2024
Q3 		$648K Hold
40,000
– – ﹤0.01% 441
2024
Q2 		$434K Hold
40,000
– – ﹤0.01% 498
2024
Q1 		$560K Buy
+40,000
New +$520K ﹤0.01% 460
2023
Q4 		– Sell
-2,287,538
Closed -$20.9M – 1471
2023
Q3 		$20.9M Hold
2,287,538
– – 0.08% 98
2023
Q2 		$16.6M Sell
2,287,538
-1,728,600
-43% -$14.9M 0.06% 105
2023
Q1 		$34M Hold
4,016,138
– – 0.13% 73
2022
Q4 		$30.2M Sell
4,016,138
-18,800
-0.5% -$146K 0.11% 77
2022
Q3 		$32.5M Hold
4,034,938
– – 0.14% 70
2022
Q2 		$46.8M Sell
4,034,938
-50,000
-1% -$590K 0.19% 60
2022
Q1 		$45.8M Buy
4,084,938
+750,022
+22% +$6.39M 0.15% 68
2021
Q4 		$21.7M Buy
3,334,916
+1,305,009
+64% +$8.95M 0.07% 111
2021
Q3 		$15.5M Buy
2,029,907
+646,907
+47% +$6.69M 0.06% 125
2021
Q2 		$17.5M Buy
+1,383,000
New +$15.2M 0.06% 121

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

First Manhattan's EOLS Position: Q3 2025 in Review

First Manhattan sold out of Evolus (EOLS) in Q3 2025, closing a stake of 150,000 shares — an estimated $1.38M sold.

First Manhattan first reported a position in EOLS in Q2 2021 and held it in 16 quarters. The position peaked at $46.8M in Q2 2022. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • First Manhattan reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • First Manhattan sold 150,000 Evolus shares in Q3 2025, an estimated $1.38M.
  • First Manhattan first reported a position in Evolus in Q2 2021 and held it in 16 quarters.
  • First Manhattan's Evolus position peaked at $46.8M in Q2 2022.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on First Manhattan's 13F filing for Q3 2025, filed 14 Nov 2025.